UK reviews NHS data contract with Palantir amid privacy concerns

Tuesday 09 - 11:15

The United Kingdom is carrying out a comprehensive review of its major data contract with U.S. technology company Palantir Technologies, which is currently working with the National Health Service (NHS), amid growing political and public debate over data privacy and long-term reliance on foreign providers.

The agreement, valued at approximately £330 million, was awarded to develop a unified data platform for the NHS. The contract is scheduled to run until early 2027, at which point the government will decide whether to extend it or terminate it under a break clause allowing continuation for up to seven years.

Technology Minister Liz Kendall stated that officials are reviewing all aspects of the deal to ensure it delivers the best outcome for the United Kingdom. She noted that concerns being assessed include patient confidentiality, public trust, and dependence on a U.S.-based technology supplier.

While government representatives highlight potential efficiency gains and improvements in healthcare data management, critics argue that the arrangement raises significant risks regarding sensitive medical information and national control over health data infrastructure.

The review comes at a time when digital governance and healthcare modernization remain central policy priorities, and it could determine the future role of large private technology firms within the NHS system.